Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Anne-Marie Gerdes.
Newcastle Authors
Title
Year
Full text
Professor John Mathers
Dr Anne-Marie Gerdes
Dr Harsh Sheth
Lynn Reed
Dr Gillian Borthwick
et al.
Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up
2022
Alexander Henderson
Dr Anne-Marie Gerdes
Oral contraceptive use and ovarian cancer risk for
BRCA1/2
mutation carriers: an international cohort study
2021
Dr Anne-Marie Gerdes
Alexander Henderson
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
2017
Professor John Mathers
Dr Mohammad Movahedi
Dr Anne-Marie Gerdes
Professor Sir John Burn
Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
2012
Professor Sir John Burn
Dr Anne-Marie Gerdes
Dr Mohammad Movahedi
Professor John Mathers
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
2011
Dr Fiona Douglas
Dr Anne-Marie Gerdes
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population
2010
Professor Sir John Burn
Professor John Mathers
Dr Anne-Marie Gerdes
Cancer Occurrence During Follow-Up of the CAPP2 Study: Aspirin Use For Up To Four Years Significantly Reduces Lynch Syndrome Cancers for up to Several Years After Completion of Therapy
2010
Professor Sir John Burn
Dr Anne-Marie Gerdes
Professor John Mathers
Aspirin prevents cancer in Lynch syndrome
2009
Professor Sir John Burn
Dr Anne-Marie Gerdes
Professor John Mathers
Aspirin prevents cancer in Lynch syndrome
2009
Dr John Beesley
Dr Anne-Marie Gerdes
Dr Fiona Douglas
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)
2009
Dr Anne-Marie Gerdes
Dr Fiona Douglas
Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
2008